DLin-MC3-DMA
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →.png)
Ionizable lipid for LNP and nucleic-acid delivery research.
di-Pal-MTO is a palm oil-based lipid produced by combining the anticancer drug mitoxantrone (MTO) with palmitoleic acid. When nanoparticles of mono-Pal-MTO and di-Pal-MTO are combined in a molar ratio of 1:1, they show effective siRNA cell delivery and enhance anticancer activity.
| CAS No. | Not available |
| Chemical Name | di-Pal-MTO |
| Synonyms | diPalMTO, di Pal MTO |
| SMILES | CCCCCC/C=C\CCCCCCCC(OCCNCCNC1=C2C(C(C3=C(O)C=CC(O)=C3C2=O)=O)=C(C=C1)NCCNCCOC(CCCCCCC/C=C\CCCCCC)=O)=O |
| Formula | C54H84N4O8 |
| M.Wt | 917.27 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 10.9019 mL | 2.1804 mL | 1.0902 mL |
| 25 mg | 27.2548 mL | 5.4510 mL | 2.7255 mL |
| 50 mg | 54.5096 mL | 10.9019 mL | 5.4510 mL |
| 100 mg | 109.0192 mL | 21.8038 mL | 10.9019 mL |
| 250 mg | 272.5479 mL | 54.5096 mL | 27.2548 mL |
Contact our team with the catalog number and requested quantity.